Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P B Caguioa

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
The American Journal of the Medical Sciences|September 1, 1994
Chronic lymphocytic leukemiaP B Caguioa, S Tansan, R P McCaffrey
Cancer|February 1, 1993
Treatment of advanced non-small cell lung cancer with very high-dose cisplatin combined with etoposide and mitomycin CP J Hesketh, S Tansan, P B Caguioa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2022
Pembrolizumab monotherapy versus chemotherapy in platinum-pretreated, recurrent or metastatic nasopharyngeal cancer (KEYNOTE-122): an open-label, randomized, phase III trialA T C Chan, V H F Lee, R-L Hong, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
The American Journal of the Medical Sciences|September 1, 1994
Chronic lymphocytic leukemiaP B Caguioa, S Tansan, R P McCaffrey
Cancer|February 1, 1993
Treatment of advanced non-small cell lung cancer with very high-dose cisplatin combined with etoposide and mitomycin CP J Hesketh, S Tansan, P B Caguioa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2022
Pembrolizumab monotherapy versus chemotherapy in platinum-pretreated, recurrent or metastatic nasopharyngeal cancer (KEYNOTE-122): an open-label, randomized, phase III trialA T C Chan, V H F Lee, R-L Hong, et al.
Pageof 1